XTSX
IFOS
Market cap288mUSD
Oct 30, Last price
2.07CAD
1D
1.97%
1Q
-8.00%
Jan 2017
-5.91%
Name
Itafos
Chart & performance
P/E
3.29
P/S
0.59
EPS
0.45
Vol. 1Y
45.62%
Shs. 5Y
6.63%
Rev. 5Y
7.67%
Div Yld LY
10.63%
Div Yld TTM
8.21%
Revenues
491m
+5.52%
Net income
88m
+2,173.79%
CFO
120m
+26.74%
Dividend
Nov 17, 20250.17 CAD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Itafos, Inc. engages in the provision of phosphate fertilizers and specialty products. It operates through the following segments: Itafos Conda, Itafos Arraias, Development and Exploration, and Corporate. The Itafos Conda segment produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, and specialty products including ammonium polyphosphate. The Itafos Arraias segment offers single superphosphate (SSP), SSP with micronutrients, premium PK compounds, and excess sulfuric acid. The Development and Exploration segment consists of activities related to Itafos in the following locations: Farim, Paris Hills, Santana, Mantaro, and Araxá. The Corporate segment includes support, administrative, and financing activities. Its Projects include Farim and Santana. The company was founded by Peter J. Marrone and Antenor F. Silva Jr. on July 9, 1999 and is headquartered in Houston, TX.
Key people
Anthony Cina
Independent Chairman of the Board · since 2020
G. David Delaney
Chief Executive Officer, Director · since 2020
George Burdette
Chief Financial Officer · since 2018
Timothy Vedder
Vice President - Operations · since 2018
David Brush
Chief Strategy Officer · since 2021
Fernando Planchart Padula
General Counsel, Secretary
Director · since 2020
Rory Oneill
Director · since 2020
Independent Director · since 2017
Ronald Wilkinson
Independent Director · since 2018
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||